Get started
Author

Valerie N. Babinsky

Observed names: Babinsky, Valerie, Babinsky, Valerie N, V.N. Babinsky, VALERIE N. BABINSKY, Valerie Babinsky, Valerie N Babinsky
Observed institutions: University of Utah, Churchill Hospital, University of Oxford, Comprehensive Cancer Center Vienna, Oxford Centre for Diabetes, Endocrinology and Metabolism, Roche (Austria), Országos Korányi Tbc és Pulmonológiai Intézet, Indiana University Indianapolis, Indiana University School of Medicine, Roche Diabetes Care GmbH (Germany), Medical University of Vienna
ORCID: 0000-0002-0586-2924
Observed ORCID: 0000-0002-0586-2924
OpenAlex ID: A5037598795
Mutations Affecting G-Protein Subunit α 11 in Hypercalcemia and Hypocalcemia
2013 · M. Andrew Nesbit, Fadil M. Hannan, et al. · New England Journal of Medicine · 405
PDF
Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis
2016 · Fadil M Hannan, Valerie N Babinsky, et al. · Journal of Molecular Endocrinology · 193
PDF
Genome-Wide miRNA Expression Profiling Identifies miR - 9 - 3 and miR - 193a as Targets for DNA Methylation in Non–Small Cell Lung Cancers
2012 · Gerwin Heller, Marlene Weinzierl, et al. · Clinical Cancer Research · 159
PDF
Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 (FHH3) demonstrate genotype–phenotype correlations, codon bias and dominant-negative effects
2015 · Fadil M. Hannan, Sarah A. Howles, et al. · Human Molecular Genetics · 89
PDF
Genome-wide CpG island methylation analyses in non-small cell lung cancer patients
2012 · Gerwin Heller, Valerie N. Babinsky, et al. · Carcinogenesis · 82
The Calcilytic Agent NPS 2143 Rectifies Hypocalcemia in a Mouse Model With an Activating Calcium-Sensing Receptor (CaSR) Mutation: Relevance to Autosomal Dominant Hypocalcemia Type 1 (ADH1)
2015 · Fadil M. Hannan, Gerard V. Walls, et al. · Endocrinology · 75
PDF
Gα11 mutation in mice causes hypocalcemia rectifiable by calcilytic therapy
2017 · Caroline M. Gorvin, Fadil M. Hannan, et al. · JCI Insight · 68
PDF
Cinacalcet for Symptomatic Hypercalcemia Caused by AP2S1 Mutations
2016 · Sarah A. Howles, Fadil M. Hannan, et al. · New England Journal of Medicine · 55
PDF
A calcium-sensing receptor mutation causing hypocalcemia disrupts a transmembrane salt bridge to activate β-arrestin–biased signaling
2018 · Caroline M. Gorvin, Valerie N. Babinsky, et al. · Science Signaling · 45
Mutant Mice With Calcium-Sensing Receptor Activation Have Hyperglycemia That Is Rectified by Calcilytic Therapy
2017 · Valerie N Babinsky, Fadil M Hannan, et al. · Endocrinology · 38
PDF
Allosteric Modulation of the Calcium-sensing Receptor Rectifies Signaling Abnormalities Associated with G-protein α-11 Mutations Causing Hypercalcemic and Hypocalcemic Disorders
2016 · Valerie N. Babinsky, Fadil M. Hannan, et al. · Journal of Biological Chemistry · 36
PDF
Time spent in target range assessed by self-monitoring blood glucose associates with glycated hemoglobin in insulin treated patients with diabetes
2020 · Antonio Cutruzzolà, Concetta Irace, et al. · Nutrition Metabolism and Cardiovascular Diseases · 30
N-ethyl-N-Nitrosourea (ENU) Induced Mutations within the Klotho Gene Lead to Ectopic Calcification and Reduced Lifespan in Mouse Models
2015 · Christopher T. Esapa, Fadil M. Hannan, et al. · PLoS ONE · 23
PDF
Association Studies of Calcium-Sensing Receptor (CaSR) Polymorphisms with Serum Concentrations of Glucose and Phosphate, and Vascular Calcification in Renal Transplant Recipients
2015 · Valerie N. Babinsky, Fadil M. Hannan, et al. · PLoS ONE · 17
PDF
Calcilytic NPSP795 Increases Plasma Calcium and PTH in an Autosomal Dominant Hypocalcemia Type 1 Mouse Model
2020 · Fadil M Hannan, Caroline M Gorvin, et al. · JBMR Plus · 11
PDF
Supplementary Figure Legend 1 from Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non–Small Cell Lung Cancers
2023 · Gerwin Heller, Marlene Weinzierl, et al.
Supplementary Figure 1 from Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non–Small Cell Lung Cancers
2023 · Gerwin Heller, Marlene Weinzierl, et al.
PDF
Supplementary Table 3 from Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non–Small Cell Lung Cancers
2023 · Gerwin Heller, Marlene Weinzierl, et al.
Supplementary Table 2 from Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non–Small Cell Lung Cancers
2023 · Gerwin Heller, Marlene Weinzierl, et al.
Supplementary Table 1 from Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non–Small Cell Lung Cancers
2023 · Gerwin Heller, Marlene Weinzierl, et al.
PDF
Data from Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non–Small Cell Lung Cancers
2023 · Gerwin Heller, Marlene Weinzierl, et al.
Data from Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non–Small Cell Lung Cancers
2023 · Gerwin Heller, Marlene Weinzierl, et al.
Supplementary Figure Legend 1 from Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non–Small Cell Lung Cancers
2023 · Gerwin Heller, Marlene Weinzierl, et al.
PDF
Supplementary Table 3 from Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non–Small Cell Lung Cancers
2023 · Gerwin Heller, Marlene Weinzierl, et al.
PDF
Supplementary Figure 1 from Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non–Small Cell Lung Cancers
2023 · Gerwin Heller, Marlene Weinzierl, et al.
Works count: 46
Citation count: 1,325
H-index: 14
I10-index: 15
Year
Topic
Type